Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience.
暂无分享,去创建一个
F. Hall | J. Levy | Rebecca A. Reed | Liqiong Liu | H. Bruckner | E. Gordon | Francisco F. Lopez | G. Cornelio | C. C. Lorenzo
暂无分享,去创建一个
F. Hall | J. Levy | Rebecca A. Reed | Liqiong Liu | H. Bruckner | E. Gordon | Francisco F. Lopez | G. Cornelio | C. C. Lorenzo